ArticleMedicine2026
Dietary vitamin B6 intake and gallstone prevalence in US adults: A cross-sectional analysis of NHANES 2017-2023.
Article in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Although mechanistic data implicate vitamin B6 in the regulation of cholesterol metabolism and inflammatory pathways, the epidemiological nexus between dietary vitamin B6 consumption and gallstone susceptibility remains largely uncharted in population-based cohorts. Leveraging cross-sectional data from the National Health and Nutrition Examination Survey (NHANES 2017-2023; n = 9273), we utilized weighted multivariable logistic regression to elucidate the association between vitamin B6 intake and self-reported gallstone history, with models rigorously adjusted for sociodemographic, lifestyle, and clinical confounders. Restricted cubic splines (RCS) were employed to delineate dose-response trajectories, while subgroup analyses served to identify potential effect modifiers. The overall prevalence of gallstones was 10.47% (971/9273). In fully adjusted models, a significant inverse correlation emerged between vitamin B6 intake and gallstone risk (OR per mg increase: 0.90; 95% CI: 0.82-0.99; P = .029). RCS analysis revealed a linear dose-response gradient, with statistical significance attained at intake levels exceeding 1.6615 mg/day (P for nonlinearity = 0.249). Stratified analyses indicated a modest yet robust inverse association among adults aged 20-39 years (OR: 0.75; 95% CI: 0.56-1.00), non-Hispanic Whites, individuals with a Poverty Income Ratio (PIR) > 4, those comorbid with diabetes or hypertension, and vigorous exercisers. Elevated dietary vitamin B6 intake correlates with a diminished prevalence of gallstones in the US adult population, particularly beyond a threshold of 1.66 mg/day. These findings suggest that specific metabolic and socioeconomic subgroups may derive disproportionate protective benefits, thereby offering critical insights for the formulation of targeted preventive interventions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.